Metformin Pharmacogenetics in Heart Failure Patients with Reduced Ejection Fraction: Impact on Metformin and Growth Differentiation Factor-15 Plasma Levels
Open Access
- 28 September 2026
- journal article
- research article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 65 (11) , 1759-1770
Abstract
No abstract availableKeywords
Funding Information
- Danish Diabetes and Endocrine Academy (OL8201)
- Arvid Nilssons Fond (Dok1780631)
- Sundhedsvidenskabelige Fakultet, Aarhus Universitet (phd0115)
- Hjerteforeningen (15-r99-a5947-22032)
- Kirsten Anthonius Memorial Fund
- Health Research Fund of Central Denmark Region
- Augustinus Fonden (15-4919)
- Aase og Ejnar Danielsens Fond (10-001657)
- Helga og Peter Kornings Fond (55027-100)
- Familien Hede Nielsens Fond
- Aarhus University Hospital
This publication has 43 references indexed in Scilit:
- Growth Differentiation Factor-15 and the Effect of Empagliflozin in Heart Failure: Findings from the EMPEROR ProgramEuropean Journal of Heart Failure, 2023
- Metformin Lowers Body Weight But Fails to Increase Insulin Sensitivity in Chronic Heart Failure Patients without Diabetes: a Randomized, Double-Blind, Placebo-Controlled StudyCardiovascular Drugs and Therapy, 2020
- A Randomised, Double-Blind, Placebo-Controlled Trial of Metformin on Myocardial Efficiency in Insulin-Resistant Chronic Heart Failure Patients without DiabetesEuropean Journal of Heart Failure, 2019
- Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical OutcomesCardiovascular Drugs and Therapy, 2017
- The pharmacogenetics of metforminDiabetologia, 2017
- Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta‐AnalysisClinical Pharmacology & Therapeutics, 2016
- Endogenous glucose production increases in response to metformin treatment in the glycogen-depleted state in humans: a randomised trialDiabetologia, 2015
- A Comprehensive Review of Drug–Drug Interactions with MetforminClinical Pharmacokinetics, 2015
- Steady-state pharmacokinetics of metformin is independent of the OCT1 genotype in healthy volunteersEuropean Journal of Clinical Pharmacology, 2015
- Risk of Fatal and Nonfatal Lactic Acidosis With Metformin Use in Type 2 Diabetes MellitusArchives of internal medicine (1960), 2003